PapersPMID:20140804
Antihyperglycaemic effect of an unusual amino acid (4-hydroxyisoleucine) in C57BL/KsJ-db/db mice.
- findings
- 3
- compound
- 1
- endpoints
- 3
- Study, every finding
- animal · not in humans
- Dose studied, every finding
- 4-hydroxyisoleucine 50 mg/kg orally
- Population, every finding
- C57BL/KsJ-db/db mice, a model of type II diabetes
What moved
How to read these marks →“4-Hydroxyisoleucine, when given orally to these mice at 50 mg kg(-1) dose level, significantly (p < 0.05) declined their elevated blood glucose, plasma insulin, triglycerides, total cholesterol, low-density lipoprotein-cholesterol levels and raised their declined plasma high-density lipoprotein-cholesterol level.”
- Increases HDL cholesterol
insufficient
- Decreases LDL cholesterol
insufficient
- Decreases total cholesterol (TC)
insufficient
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- C57BL/KsJ-db/db mice (type II diabetes model); 4-hydroxyisoleucine isolated from Trigonella foenum-graecum seeds, given orally
- Participants
- not reported
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 6